Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Brian Dean

1-50 of 162 results

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

scientific article published on 08 October 2010

Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia

scientific article published on 01 July 2000

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

scientific article published in January 2001

Towards a muscarinic hypothesis of schizophrenia.

scientific article published on 5 December 2006

Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA

scientific article (publication date: April 2008)

Molecular profiles of schizophrenia in the CNS at different stages of illness.

scientific article published on 16 August 2008

Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia.

scientific article

Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation

scientific article published in September 2000

Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology

scientific article

Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment

scientific article

Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation

scientific article published on 10 May 2006

Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex

scientific article published in April 1999

Autophagy has a key role in the pathophysiology of schizophrenia

scientific article

Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder

scientific article published on August 2003

Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia.

scientific article published on 4 March 2008

Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder

scientific article published in April 2006

Decreased frontal cortical serotonin2A receptors in schizophrenia

scientific article published in September 1996

Phospholipase C-beta1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration

scientific article published on 31 July 2007

A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia

scientific article

Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders

scientific article published on December 20, 2011

Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia

scientific article published in April 2007

SLC25A12 expression is associated with neurite outgrowth and is upregulated in the prefrontal cortex of autistic subjects

scientific article

Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation

scientific article published on 2 July 2008

The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia

scientific article

Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia.

scientific article published on 17 January 2007

Evidence for disruption of sphingolipid metabolism in schizophrenia.

scientific article published on January 2009

Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder

scientific article published in January 2010

Cortical glutamatergic markers in schizophrenia

scientific article published in August 2005

Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects

scientific article

Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders

scientific article

Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies

scientific article published on December 15, 2010

Cholinergic connectivity: it's implications for psychiatric disorders.

scientific article published on 3 May 2013

Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder

scientific article

GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients

scientific article published in December 2004

Normal human aging and early-stage schizophrenia share common molecular profiles.

scientific article published on 26 February 2009

Muscarinic receptors in schizophrenia.

scientific article

Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors

scientific article published in May 1998

Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain

scientific article published in May 2007

Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.

scientific article published in January 2002

Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA.

scientific article published on 19 February 2013

Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens.

scientific article published in May 2005

Serotonin2 receptors and the serotonin transporter in the schizophrenic brain

scientific article published in January 1996

Confirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience

scientific article published on February 1998

Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine

scientific article published in January 1996

Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice

scientific article published on 28 November 2007

Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype

scientific article published on 29 April 2009

A proposed pathological model in the hippocampus of subjects with schizophrenia

scientific article

Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia.

scientific article published in September 2003

Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia

scientific article published on 17 February 2012

Role of the cholinergic system in the pathology and treatment of schizophrenia.

scientific article published on January 2009